tiprankstipranks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market
Holding SG:8YY?
Track your performance easily

Biolidics Ltd. (8YY) Income Statement

0 Followers

Biolidics Ltd. Income Statement

Last quarter (Q4 2021), Biolidics Ltd.'s total revenue was S$―, a decrease of ― from the same quarter last year. In Q4, Biolidics Ltd.'s net income was S$―. See Biolidics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-S$ 2.31MS$ 8.91MS$ 1.44MS$ 1.27MS$ 2.08M
Cost of Revenue
-S$ 1.83MS$ 5.47MS$ 471.95KS$ 387.78KS$ 724.90K
Gross Profit
-S$ 483.09KS$ 3.44MS$ 966.13KS$ 880.13KS$ 1.36M
Operating Expense
-S$ 3.80MS$ 4.02MS$ 3.31MS$ 5.72MS$ 3.07M
Operating Income
-S$ -3.31MS$ -577.88KS$ -2.34MS$ -4.84MS$ -1.72M
Net Non Operating Interest Income Expense
-S$ -206.61KS$ -100.05KS$ 107.90KS$ -575.67KS$ -1.18M
Other Income Expense
------
Pretax Income
-S$ -6.04MS$ -4.68MS$ -4.81MS$ -6.25MS$ -7.21M
Tax Provision
-S$ -56.59KS$ -33.01KS$ 0.00S$ 0.00S$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-S$ -5.98MS$ -4.65MS$ -4.81MS$ -6.25MS$ -7.21M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---S$ 10.81KS$ 220.43K-
Total Expenses
-S$ 5.63MS$ 9.49MS$ 3.78MS$ 6.10MS$ 3.80M
Net Income From Continuing And Discontinued Operation
-S$ -5.98MS$ -4.65MS$ -4.81MS$ -6.25MS$ -7.21M
Normalized Income
-S$ -5.98MS$ -4.65MS$ -4.82MS$ -6.07MS$ -7.21M
Interest Expense
-S$ 208.35KS$ 127.25KS$ 6.35KS$ 575.67KS$ 1.18M
EBIT
-S$ -5.83MS$ -4.56MS$ -4.80MS$ -5.68MS$ -6.03M
EBITDA
-S$ -4.58MS$ -3.56MS$ -4.16MS$ -5.28MS$ -5.53M
Currency in SGD

Biolidics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis